<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-109 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-109</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-109</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-9.html">extraction-schema-9</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of combination therapy strategies used to overcome late or acquired immunotherapy resistance in melanoma, including details on therapy types, mechanisms of resistance, rationale for combinations, study design, clinical or preclinical outcomes, biomarkers, adverse events, and any reported limitations or failures.</div>
                <p><strong>Paper ID:</strong> paper-f17bc0d4fc4606ff930c57a4b9fda76dda6be42f</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/f17bc0d4fc4606ff930c57a4b9fda76dda6be42f" target="_blank">Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients</a></p>
                <p><strong>Paper Venue:</strong> Genes and Diseases</p>
                <p><strong>Paper TL;DR:</strong> Understanding of PD-1 and PD-L1 in recent years, their signaling networks, interaction with other molecules, regulations of their expressions and functions in both normal and tumor tissue microenvironments are crucial to find and design therapeutic agents that block this pathway and improve the treatment efficacy.</p>
                <p><strong>Cost:</strong> 0.001</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <p class="empty-note">No extracted data.</p>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <p class="empty-note">No potentially relevant new papers extracted.</p>
        </div>

        </div>

    </div>
</body>
</html>